Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
alzheimer's disease
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
san francisco blog main
89bio
adrian krainer
alexion pharmaceuticals
allergan
alzheimer europe conference
astrazeneca
bain capital
biogen
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cerevel therapeutics
convergence pharmaceuticals
crispr
crispr therapeutics
cynthia collins
cystic fibrosis
deals
detroit blog main
detroit top stories
dicerna pharmaceuticals
drugs
ed kaye
editas medicine
eisai
eli lilly
european society for medical oncology
What
biotech
research
2
×
abbvie
alliance
alzheimer’s
annual
assessed
attention
bio
communities
conference
drug
editas
editing
esmo
europe
exits
experimental
gene
genetic
germany
hosted
investment
medicines
munich
pact
partnership
prices
pruning
puzzle
returning
rights
roundup
terminated
treatment
turned
week
Language
unset
Current search:
abbvie
×
research
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
